Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO Transcript
Corbus Pharmaceuticals Holdings, Inc. provided an update on the clinical data from its Phase 1/2 study of CRB-701 during a conference call. The discussion included insights from various participants, including the CEO and representatives from notable research firms. This update was presented at the ASCO conference, highlighting the company's ongoing research efforts.
- ▪Corbus Pharmaceuticals Holdings, Inc. discussed clinical data from its Phase 1/2 study of CRB-701.
- ▪The update was presented during a conference call at the ASCO conference.
- ▪Participants included the CEO and representatives from several research firms.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4908828-corbus-pharmaceuticals-holdings-inc-crbp-discusses-clinical-data-update-from-phase-1-2-study"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
